You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 13, July 12, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (51)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Alert me on articles by topic

Enteric Infections and Diarrhea in Human Immunodeficiency Virus–Infected Persons

Prospective Community-Based Cohort Study

Rainer Weber, MD; Bruno Ledergerber, PhD; Reinhard Zbinden, MD; Martin Altwegg, PhD; Gaby E. Pfyffer, PhD; Max A. Spycher, MD; Jakob Briner, MD; Laurent Kaiser, MD; Milos Opravil, MD; Christa Meyenberger, MD; Markus Flepp, MD; for the Swiss HIV Cohort Study

Arch Intern Med. 1999;159:1473-1480.

Background  Persons infected with human immunodeficiency virus (HIV) are at increased risk for diarrhea and enteric infections. We studied (1) the epidemiology of enteric pathogens associated with diarrhea, (2) the diagnostic yield of stool examination and endoscopic evaluation, (3) risks to develop diarrhea, and (4) the impact of diarrhea on patients' survival.

Methods  A total of 1933 participants in the Swiss HIV Cohort Study were prospectively followed up for a median of 25.5 months. A total of 560 diarrheal episodes were evaluated by standardized stool examination. Endoscopic evaluation was performed in 25% of patients with chronic diarrhea.

Results  The incidence of diarrhea was 14.2 per 100 person-years (95% confidence interval, 13.0-15.4). Among patients with CD4 cell counts below 0.05x109/L, the probability to develop diarrhea within 1, 2, and 3 years was 48.5%, 74.3%, and 95.6%, respectively. The risk to develop diarrhea was increased among patients with severe immunodeficiency, homosexual men, and patients taking antiretroviral therapy. Pneumocystis carinii chemoprophylaxis did not reduce the risk of diarrhea. Diarrhea was an independent negative predictor of survival. Enteric pathogens were detected in 16.5% of 212 acute diarrheal episodes and in 46% of 348 chronic diarrheal episodes. The sensitivity of histological and stool examination was similar except for the diagnosis of intestinal cytomegalovirus infection and leishmaniasis, which required invasive evaluation.

Conclusions  Intestinal infections were diagnosed in less than 50% of chronic diarrheal episodes. The prevalence of enteric pathogens tended to decrease during the observation period, possibly because of improved antiretroviral therapy. Endoscopic evaluation did not improve the diagnostic yield compared with stool examination except for the diagnosis of cytomegalovirus enteritis and leishmaniasis.


From the Divisions of Infectious Diseases and Hospital Epidemiology (Drs Weber, Ledergerber, Opravil, and Flepp) and Gastroenterology (Dr Meyenberger), Department of Medicine, and Institute of Clinical Pathology, Department of Pathology (Drs Spycher and Briner), University Hospital, Zurich, Switzerland; Swiss National Center for Mycobacteria (Dr Pfyffer), Department of Medical Microbiology (Drs Zbinden and Altwegg), University of Zurich; and Division of Infectious Diseases, University Hospital, Geneva, Switzerland (Dr Kaiser). A list of the members of the Swiss HIV Cohort Study appears below.


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(13):1503.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gastrointestinal complications of HIV infection: changing priorities in the HAART era
Wilcox and Saag
Gut 2008;57:861-870.
ABSTRACT | FULL TEXT  

DIARRHEAL DISEASE AMONG HIV-INFECTED ADULTS IN KARNATAKA, INDIA: EVALUATION OF RISK FACTORS AND ETIOLOGY
BECKER et al.
Am J Trop Med Hyg 2007;76:718-722.
ABSTRACT | FULL TEXT  

Prevalence and species distribution of e. Histolytica and e. Dispar in the venda region, limpopo, South Africa.
SAMIE et al.
Am J Trop Med Hyg 2006;75:565-571.
ABSTRACT | FULL TEXT  

Sensitivity and Specificity of a Monoclonal Antibody-Based Fluorescence Assay for Detecting Enterocytozoon bieneusi Spores in Feces of Simian Immunodeficiency Virus-Infected Macaques
Singh et al.
CVI 2005;12:1141-1144.
ABSTRACT | FULL TEXT  

Zoonotic Potential of the Microsporidia
Mathis et al.
Clin. Microbiol. Rev. 2005;18:423-445.
ABSTRACT | FULL TEXT  

ISOSPORIASIS IN VENEZUELAN ADULTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS: CLINICAL CHARACTERIZATION
CERTAD et al.
Am J Trop Med Hyg 2003;69:217-222.
ABSTRACT | FULL TEXT  

Molecular Characterization of Cryptosporidium Isolates Obtained from Human Immunodeficiency Virus-Infected Individuals Living in Switzerland, Kenya, and the United States
Morgan et al.
J. Clin. Microbiol. 2000;38:1180-1183.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.